KAHR is a clinical stage company developing novel immune-recruiting therapies that treat cancer at the source by unleashing the synergistic power of the body's innate and adaptive immune responses...
KAHR develops innovative immuno-recruitment cancer drugs that activate immune responses by converting cancer camouflage into beacons for the immune system to attack.